Sony (NYSE: SONY) shares soared 9% in Tokyo on Friday following strong earnings from its gaming and music divisions. The company’s PlayStation 5 saw impressive sales of 9.4 million units during the holiday season, driving a 37% surge in quarterly profit for its gaming unit.
Analysts highlighted PlayStation’s dominance in the high-performance console market, with robust software sales despite the absence of major new releases. Jefferies analyst Atul Goyal noted that game margins still have significant growth potential.
Beyond gaming, Sony’s music division also delivered strong profits, helping to counterbalance weakness in its pictures segment. Investors remain optimistic as Sony prepares for new game releases that could further boost demand.
Sony also announced a share buyback program, planning to repurchase up to 30 million shares for approximately 50 billion yen. Additionally, President Hiroki Totoki will take over as CEO in April, a move expected to influence the company's strategic direction.
With strong PlayStation sales, expanding software revenue, and growth in its music business, Sony continues to solidify its position in the tech and entertainment industries.


Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth
Apple Turns 50: From Garage Startup to AI Crossroads
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
Star Entertainment Secures $390M Refinancing Deal to Stabilize Operations
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
Brazil Meat Exports Weather Iran War Disruptions With Rerouted Shipments
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure 



